Industry-supported Lecture Series by MSD
Friday, October 16th 2026
11:30-12:30 CEST
Hall B
Mechanism of Resistance and Molecular Pathways involved in CLL Progression
| Agenda | |||
|---|---|---|---|
| 11:30-11:33 | Welcome and Introduction Jacqueline Barrientos, Mount Sinai Medical Center, Florida USA |
||
| 11:33-11:48 | Mechanism of Resistance and Molecular Pathways involved in CLL Progression Jacqueline Barrientos, Mount Sinai Medical Center, Florida USA |
||
| 11:48-11:53 | Discussion and Questions Jacqueline Barrientos, Mount Sinai Medical Center, Florida USA |
||
| 11:53-11:55 | Closing Remarks Jacqueline Barrientos, Mount Sinai Medical Center, Florida USA |
||
Agenda may be subject to change pending speaker confirmation
11:55-12:05 Break
Targeting DLBCL in 2026: From CD20 to Precision Medicine
| Agenda | |||
|---|---|---|---|
| 12:05-12:07 | Welcome and Introduction Georg Lenz, Münster University Hospital, Germany |
||
| 12:07-12:15 | Why R-CHOP is no Longer the Whole Story Georg Lenz, Münster University Hospital, Germany |
||
| 12:15-12:23 | Novel MOA and Rationale in DLBCL Georg Lenz, Münster University Hospital, Germany |
||
| 12:23-12:28 | Discussion and Questions Georg Lenz, Münster University Hospital, Germany |
||
| 12:28-12:30 | Closing Remarks Georg Lenz, Münster University Hospital, Germany |
||
Agenda may be subject to change pending speaker confirmation